VISN22 East Sites Attachment B - Blood Products and Services Volumes_04-23-2024.xlsx
XLSX spreadsheet 50 KB Posted
- Solicitation number
- 36C26224Q1010
About this file
This document appears to be an attachment or appendix to a federal government solicitation for blood products and laboratory services. It contains detailed pricing information and estimated annual quantities for various blood products and testing services required across three locations - Phoenix, Prescott, and Albuquerque. The products include leukoreduced whole blood, red blood cells, fresh frozen plasma, cryoprecipitated products, and platelets. The services cover a wide range of laboratory testing and processing, such as antigen typing, antibody identification, CMV testing, irradiation, and molecular genotyping. The pricing is provided for a 5-year performance period, with unit prices and extended annual costs. The document also includes details on return credits, STAT and ASAP delivery fees, and other modifiers that may apply. This information appears to be part of a larger solicitation for the VISN22 East Sites, issued by the Department of Veterans Affairs.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C26224Q1010.docx | DOCX document | |
| Attachment C- Business Associate Agreement BAA Template.doc | DOC document | |
| Attachment A VA Handbook 6500.6_Appendix C.pdf | ||
| S02 - 36C26224Q1010_4-30-2024_.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
1. Blood Products Phoenix
| COMPONENTS | Estimated Annual Quantity | |||||||||||
| Phoenix | Unit Price Performance Year #1 | Extended Price Perormance Year #1 | Unit Price Performance Year #2 | Extended Price Performance Year #2 | Unit Price Performance Year #3 | Extended Price Performance Year #3 | Unit Price Performance Year #4 | Extended Price Performance Year #4 | Unit Price Performance Year #5 | Extended Price Performance Year #5 | Product/Stock Numbers | |
| Leukoreduced Whole Blood | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Leukoreduced Red Blood Cells | 1500 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Red Blood Cells Restocking Fee (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Fresh Frozen Plasma Restocking Fee (returned >6 months until expiring) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Fresh Frozen Plasma (200-400ml) | 130 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Pools | 30 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Pools Restocking Fee (returned >6 months until expiring) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Single | 12 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Single Restocking Fee (returned >6 months until expiring) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Pathogen Reduced Platelets/Psoralen | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| LVDS >36 Platelets | 50 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Performance Year #1 | Performace Year #2 | Performance Year #3 | Performance Year #4 | Performance Year #5 | |
| Return Credit for RBCs >14 Days (As a Percentage). (If no return credit, enter 0) |
2. Blood Services Phoenix
| Services | Estimated Annual Quantity (Based on a average of 4 Years) | |||||||||||||||
| Phoenix | Unit Price Performance Year #1 | Extended Price Perormance Year #1 | Unit Price Performance Year #2 | Extended Price Performance Year #2 | Unit Price Performance Year #3 | Extended Price Performance Year #3 | Unit Price Performance Year #4 | Extended Price Performance Year #4 | Unit Price Performance Year #5 | Extended Price Performance Year #5 | Product/Stock Numbers | Performing Laboratory Location (Include, City, County and State) | Performing Laboratory CLIA Accreditation | Contractor Turnaround Time (TAT) | ||
| Autologous Fee | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Directed Donor Fee | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Autologous/Directed Transport | 7 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| ABO – Patient | 32 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| ABO/Rh | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| ABO Discrepancy | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Direct Antiglobulin Test | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| DAT NEG AIHA Eval | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Enzyme Panel | 30 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Prewarm Setup | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Adsorption Procedure | 32 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Enzyme Treatment | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Enzyme Panel-manufactured | 32 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Elution Procedure | 12 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Red Cell Separation Method | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Red Cell Treatment | 12 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Red Cell Stroma Allo | 12 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Serum Treatment w/Chem | 32 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Serum neut/Inhib | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Donath-Lan. Test | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antibody I.D. Panel | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antibody ID Panel Rare | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antibody Screening | 32 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 4C Antibody Screen | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Titration Studies (per Tit.) | 32 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Cold Agglutinin Titer | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Pathological Cold Agg. | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Rare Unit Fee, per comp | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| CMV Testing (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Hemoglobin S-product | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Unconfirmed Antigen Request, per component | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA Selected PLT Fee, per Comp. | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Crossmatched PLT Tagging, per comp. | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Irradiation (per component) | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Platelet Antibody Screen | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Platelet Crossmatch (per strip tested) | 200 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Rh(D) Typing | 15 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Sample Handling Fee | 15 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Hgb S-Screen | 32 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| STAT Processing Fee (product) | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| STAT Ordering Fee (product) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| STAT Request-Sample workup | 35 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| On Call Fee (non-bus hrs) | 35 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| ASAP Order Fee (Product)* | 32 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| ASAP Request -Sample workup | 14 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Washing (per component) | 50 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Compatibility Screen | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Plasma Thawing | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Blood Type Recheck | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Donor/Product Search Fee, per search | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Rare Search Fee, per search | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| ARDP Fee, per unit | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Import Fee, per unit | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| CMV Neg, per comp | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Deglycerolization (per component) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| External TS/ESP Initial Setup | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| External TS/ESP Service Fee, monthly | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| External TS/ESR Stocking Fee, Monthly | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Specimen Hold, each | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| STAT Delivery Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| ASAP Delivery Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Molecular Sequencing Test | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Molecular Extended Red Cell genotype/phenotype testing | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Molecular Genotype-Platelet (HPA) | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Typing, Patient, Per Antigen | 8 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Typing, Patient, Rare, Per Antigen | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Typing, Donor, Per Antigen | 50 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Typing, Rare, Per Antigen | 10 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Typing, Donor-Confirmation/History | 200 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Screen 1 - 10 (per unit) | 10 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Screen 11 - 20 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Screen 21 - 30 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Screen 31 - 40 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Screen 41 - 50 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Screen 51 - 60 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Antigen Screen 61 - 70 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| RHD Genotype Test | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| RHCE Genotype Test | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Rho Immune Globulin | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA Ab scn | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA Ab ID CI | 12 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA Ab ID CII | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA Class I (A,B) | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Donor Testing HLA I | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Donor Search | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA (A,B,DR) IR | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA-Type for Patient & Donor | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA Class I Type | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA Class II Type | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA-DPA1 HR | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| HLA-DQA1 HR | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Priority Reference Testing | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| STAT Charge After Hour Reference Testing | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| Return Credit for RBCs >14 Days (As a Percentage) | ||||||||||||||||
| (If no return credit, enter 0) | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
* Estimated total annual number of special deliveries 150
3. Blood Products Prescott
| COMPONENTS | Estimated Annual Quantity | |||||||||||
| Prescott | Unit Price Performance Year #1 | Extended Price Perormance Year #1 | Unit Price Performance Year #2 | Extended Price Performance Year #2 | Unit Price Performance Year #3 | Extended Price Performance Year #3 | Unit Price Performance Year #4 | Extended Price Performance Year #4 | Unit Price Performance Year #5 | Extended Price Performance Year #5 | Product/Stock Numbers | |
| Leukoreduced Whole Blood | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Leukoreduced Red Blood Cells | 200 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Red Blood Cells Restocking Fee (per unit) | 90 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Fresh Frozen Plasma (200-400ml) | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Fresh Frozen Plasma Restocking Fee (returned >6 months until expiring) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Pools | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Pools Restocking Fee (returned >6 months until expiring) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Single | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Single Restocking Fee (returned >6 months until expiring) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Pathogen Reduced Platelets//Psoralen | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| LVDS >36 Platelets | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Performance Year #1 | Performace Year #2 | Performance Year #3 | Performance Year #4 | Performance Year #5 | |
| Return Credit for RBCs >14 Days (As a Percentage). (If no return credit, enter 0) |
4. Blood Services Prescott
| Services | Estimated Annual Quantity (Based on a average of 4 Years) | ||||||||||||||
| Prescott | Unit Price Performance Year #1 | Extended Price Perormance Year #1 | Unit Price Performance Year #2 | Extended Price Performance Year #2 | Unit Price Performance Year #3 | Extended Price Performance Year #3 | Unit Price Performance Year #4 | Extended Price Performance Year #4 | Unit Price Performance Year #5 | Extended Price Performance Year #5 | Product/Stock Numbers | Performing Laboratory Location (Include, City, County and State) | Performing Laboratory CLIA Accreditation | Contractor Turnaround Time (TAT) | |
| Autologous Collection (per component) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Directed Collection (per component) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Autologous/Directed Transport | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| ABO – Patient | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Aliquot Bags, Pediatric (attached, per set) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antibody I.D. (complex – may include elution and/or absorption) | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antibody I.D. (routine) | 10 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antibody Screening | 10 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antibody Titer | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 1 - 10 (per unit) | 12 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 11 - 20 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 21 - 30 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 31 - 40 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 41 - 50 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 51 - 60 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 61 - 70 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| CMV Testing (per unit) | 75 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Freezing/Deglycerolization (per compenent) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| HLA Matched Platelets (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Irradiation (per component) | 75 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Lymphocyte Collection/Research | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Peripheral Stem Cell Processing | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Platelet Antibody Screen | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Platelet Crossmatch (per unit shipped) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Rare Unit Search | 10 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Rh – Patient | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Sample Collections | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Sickle Cell Testing (per unit) | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| STAT Fee (Product, During Business Hours) * | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| STAT Fee (Product, Non Business Hours) * | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| STAT Fee (Sample, During Business Hours) * | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| STAT Fee (Sample, Non Business Hours) * | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Washing (per component) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Molecular genotype testing | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Modifiers (Added to Unit Cost) | ||||||
| Freezing | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Type AB FP Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Type AB Single Cryo Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Type AB Cryo Pool Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Type ON RBC Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Unscheduled Delivery Fee (Products) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| STAT Processing Fee (Products) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| * Estimated total annual number of special deliveries | 25 |
5. Blood Products ABQ
| COMPONENTS | Estimated Annual Quantity | |||||||||||
| ABQ | Unit Price Performance Year #1 | Extended Price Perormance Year #1 | Unit Price Performance Year #2 | Extended Price Performance Year #2 | Unit Price Performance Year #3 | Extended Price Performance Year #3 | Unit Price Performance Year #4 | Extended Price Performance Year #4 | Unit Price Performance Year #5 | Extended Price Performance Year #5 | Product/Stock Numbers | |
| Leukoreduced Whole Blood | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Leukoreduced Red Blood Cells | 665 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Red Blood Cells Restocking Fee (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Fresh Frozen Plasma (200-400ml) | 85 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Fresh Frozen Plasma Restocking Fee (returned >6 months until expiring) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Pools | 11 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Pools Restocking Fee (returned >6 months until expiring) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Single | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Cryoprecipitated AHF Single Restocking Fee (returned >6 months until expiring) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Pathogen Reduced Platelets | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| LVDS >36 Platelets | 78 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Performance Year #1 | Performace Year #2 | Performance Year #3 | Performance Year #4 | Performance Year #5 | ||||||||
| Return Credit for RBCs >14 Days (As a Percentage). (If no return credit, enter 0) |
6. Blood Services ABQ
| Services | Estimated Annual Quantity (Based on a average of 4 Years) | ||||||||||||||
| ABQ | Unit Price Performance Year #1 | Extended Price Perormance Year #1 | Unit Price Performance Year #2 | Extended Price Performance Year #2 | Unit Price Performance Year #3 | Extended Price Performance Year #3 | Unit Price Performance Year #4 | Extended Price Performance Year #4 | Unit Price Performance Year #5 | Extended Price Performance Year #5 | Product/Stock Numbers | Performing Laboratory Location (Include, City, County and State) | Performing Laboratory CLIA Accreditation | Contractor Turnaround Time (TAT) | |
| Autologous Collection (per component) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Directed Collection (per component) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Autologous/Directed Transport | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| ABO – Patient | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antibody I.D. (complex – may include elution and/or absorption) | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antibody I.D. (routine) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antibody Screening | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antibody Titer | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 1 - 10 (per unit) | 16 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 11 - 20 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 21 - 30 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 31 - 40 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 41 - 50 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 51 - 60 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Antigen Screen 61 - 70 (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| CMV Testing (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Freezing/Deglycerolization (per compenent) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| HLA Matched Platelets (per unit) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Irradiation (per component) | 120 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Lymphocyte Collection/Research | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Peripheral Stem Cell Processing | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Platelet Antibody Screen | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Platelet Crossmatch (per unit shipped) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Rare Unit Search | 10 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Rh – Patient | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Sample Collections | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Sickle Cell Testing (per unit) | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| STAT Fee (Product, During Business Hours) * | 20 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| STAT Fee (Product, Non Business Hours) * | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| STAT Fee (Sample, During Business Hours) * | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| STAT Fee (Sample, Non Business Hours) * | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Washing (per component) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| Molecular genotype testing | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| ASAP Fee (Product, During Business Hours) * | 20 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| ASAP Fee (Product, Non Business Hours) * | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Modifiers (Added to Unit Cost) | ||||||
| Freezing | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Type AB FP Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Type AB Single Cryo Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Type AB Cryo Pool Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Type ON RBC Fee | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Unscheduled Delivery Fee (Products) | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| STAT Processing Fee (Products) | 3 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| * Estimated total annual number of special deliveries | 150 |
7. Return Percentage Data
| Phoenix | Prescott | ABQ | |
| Under Current Returns Policy - Current Monthly Return Rate for Blood Units (%) | 6% | 70% | <2% |
File details come from the government source that posted it. Updated .